A Preview Of Mersana Therapeutics's Earnings
Portfolio Pulse from Benzinga Insights
Mersana Therapeutics (NASDAQ:MRSN) is set to release its latest quarterly earnings report on November 7, 2023. Analysts estimate an earnings per share (EPS) of $-0.36. The company's past performance shows a mixed trend of beating and missing EPS estimates, with corresponding changes in share price. The stock is currently trading at $1.42, down 78.69% over the last 52-week period.
November 06, 2023 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Mersana Therapeutics is expected to report an EPS of $-0.36 in its upcoming earnings. The stock has been on a downward trend, losing 78.69% over the past year.
The company's stock has been on a downward trend, losing nearly 80% of its value over the past year. This, combined with the expected negative EPS, could potentially lead to further decline in the short term. However, any positive guidance for future quarters could mitigate this impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100